The aggressive localized periodontitis (LAgP) is localized and mainly affects the first molars and permanent incisors. It has an early onset in adolescents or young adults, often with rapid progression, for which adequate treatment in advance of the disease can arrest or reverse the progression of the disease. The main accomplices of LAgP are the hormonal changes that occur during puberty and the fact that the first molars and incisors are the first permanent teeth to erupt, so
the microbial environment may differ compared to when the next teeth emerge.
Pathophysiological studies of the disease have also revealed substantial differences between LAgP and chronic periodontitis CP in both microbiological and immunological responses, although much additional research is needed to fully understand the mechanisms of diseases.
Materials and methods
In a critical non-systematic review, published on JADA November 2019, the authors evaluated the study published in literature about localized aggressive periodontitis (LAgP) compared to chronic periodontitis (CP), specifically analyzing the potential differences in epidemiology, microbiology, immunology, genetics and response to therapy. The purpose of this review is to summarize the vast body of solid evidence supporting the recognition and classification of LAgP as a separate and distinct sub-category from periodontitis in order to stimulate more and more specific research and studies on LAgP.
Results
LAgP differs from CP by localization to incisors and first molars, early onset and rapid
progression in adolescents and young adults, and a 10-fold higher prevalence in populations of
African or Middle Eastern origin, often with strong familial aggregation. The bacterium Aggregatibacter actinomycetemcomitans and hyperresponsive neutrophils are frequently observed. Antibiotic and nonsurgical therapies are highly effective.
Conclusions
From the data of this review, which must be confirmed in other reviews and similar studies, it can be concluded that LAgP differs in many ways from chronic periodontitis (CP) which is much more common and affects the elderly.
The substantial evidence of differences summarized in this review strongly supports the classification of LAgP as a distinct form of periodontitis.
Classifying LAgP as a distinct subcategory of periodontitis will encourage future research and does not conflict with the newly proposed “staging and grading” system. The silent onset and rapid progression of LAgP make early diagnosis and frequent follow-up with patients essential for effective treatment.
For additional informations: Unique etiologic, demographic, and pathologic characteristics of localized aggressive periodontitis support classification as a distinct subcategory of periodontitis.
Italian version: http://www.odontoiatria33.it/parodontologia/18648/parodontite-aggressiva-localizzata.html
Aggressive periodontitis is a destructive disease characterized by the following: the involvement of multiple teeth with a distinctive pattern of periodontal tissue loss; a high rate of disease...
Periodontology 09 April 2025
Periodontitis is a chronic inflammatory non-communicable disease (NCD) characterised by the destruction of the tooth-supporting apparatus (periodontium), including alveolar bone, the presence of...
Periodontology 21 February 2025
Periodontology 08 November 2024
Microbiology in Diagnosis and Treatment of Severe Periodontitis. A Report of Four Cases
The purpose of this report is to illustrate the use of microbiology in the diagnosis and treatment in four cases of severe adult periodontitis.
Endodontics 21 September 2023
The authors previously demonstrated that auxiliary metformin therapy promotes healing of apical periodontitis. Here, the team aimed to investigate the effects of metformin on osteoblast...
Products 01 September 2026
George Freedman gives readers a brief summary of products that have recently been introduced to dentistry, based on his clinical experience.
News 01 September 2026
Partnership leverages BioHorizons’ commercial network to broaden availability of Xtant’s allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand
News 01 September 2026
(“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, recently announced several key initiatives to support the drive toward ca
Editorials 01 September 2026
The forerunner of what’s now Texas A&M College of Dentistry opened 120 years ago in Dallas with the mission of educating dentists to provide quality care to patients in North Texas
Oral pathology 01 September 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...